• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab
 
  • Details
  • Full
Options
2022
Journal Article
Title

Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab

Abstract
Cold-induced urticaria (ColdU) is a common form of chronic inducible urticaria. It is characterized by the development of wheals and, sometimes, angioedema upon skin exposure to cold air, liquids, or objects.1 Although considerable progress has been made over the last years in the understanding of the condition and its treatment, ColdU remains a challenging clinical problem. Patients often suffer from ColdU for years before they are diagnosed, and treatment requires a personalized approach. Similar to other forms of chronic urticaria, ColdU has a significant impact on quality of life.1 Here, we describe a case of severe and refractory ColdU associated with cryoglobulinemia and successfully treated with rituximab.
Author(s)
Stroet, L.C.
Hermans, M.A.W.
Maurer, M.
Doorn, M.B.A. van
Journal
JAAD case reports  
Open Access
DOI
10.1016/j.jdcr.2021.10.032
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024